| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5290804
Max Phase: Preclinical
Molecular Formula: C19H11Cl2N5O3
Molecular Weight: 428.24
Associated Items:
Representations
Canonical SMILES: COc1ccc2c(ccn2-c2c(Cl)cc(-n3nc(C#N)c(=O)[nH]c3=O)cc2Cl)c1
Standard InChI: InChI=1S/C19H11Cl2N5O3/c1-29-12-2-3-16-10(6-12)4-5-25(16)17-13(20)7-11(8-14(17)21)26-19(28)23-18(27)15(9-22)24-26/h2-8H,1H3,(H,23,27,28)
Standard InChI Key: OQEIQUOAQQFLAI-UHFFFAOYSA-N
Associated Targets(Human)
THRA Tclin Thyroid hormone receptor alpha (894 Activities)
THRB Tclin Thyroid hormone receptor beta-1 (7926 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 428.24 | Molecular Weight (Monoisotopic): 427.0239 | AlogP: 3.05 | #Rotatable Bonds: 3 |
| Polar Surface Area: 105.70 | Molecular Species: ACID | HBA: 7 | HBD: 1 |
| #RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 5.65 | CX Basic pKa: | CX LogP: 4.23 | CX LogD: 2.69 |
| Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.54 | Np Likeness Score: -1.31 |
References
| 1. Hu L, Gu Y, Liang J, Ning M, Yang J, Zhang Y, Qu H, Yang Y, Leng Y, Zhou B.. (2023) Discovery of Highly Potent and Selective Thyroid Hormone Receptor β Agonists for the Treatment of Nonalcoholic Steatohepatitis., 66 (5): [PMID:36799411] [10.1021/acs.jmedchem.2c01669] |
Source
Source(1):